At a glance
ClinicalIndex Comparison RecordN/ACompleted· 126 enrolled
Drug / intervention
3% hydrogen peroxide solution with HydraGlyde® Moisture Matrix +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study of CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers
In Brief
A clinical study evaluating 3% hydrogen peroxide solution with HydraGlyde® Moisture Matrix, Habitual Multi-Purpose Contact Lens Solution, and 1 other intervention for Presbyopia. Completed, enrolled 126 participants.
Detailed Summary
The purpose of this study is to evaluate CLEAR CARE® PLUS (CCP) compared to non-HYDRAGLYDE® multi-purpose contact lens solutions in presbyopes currently wearing soft contact lenses and experiencing symptoms of dryness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartDec 2016
Primary CompletionMar 2017
TodayJul 2026
First PostedNov 17, 2016
Enrollment StartDec 13, 2016
Primary CompletionMar 24, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.6 years ago
Interventions
3% hydrogen peroxide solution with HydraGlyde® Moisture Matrixdevice
For cleaning, disinfection and overnight storage of contact lenses
Habitual Multi-Purpose Contact Lens Solutiondevice
Habitual Contact Lensesdevice
Participant's habitual contact lens brand worn in a daily wear modality for 30 days.